Natriuretic Peptides 2008: Updated Biology, Therapeutic Uses, and Cardiovascular Disease Implications

Updated comprehensive review of natriuretic peptide biology (ANP, BNP, CNP, DNP, urodilatin), therapeutic applications (nesiritide, sacubitril concept), and cardiovascular disease biomarker/therapy roles.

Rubattu, Speranza et al.·American journal of hypertension·2008·Moderate EvidenceReview
RPEP-01410ReviewModerate Evidence2008RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Updated natriuretic peptide review covering expanded family (ANP, BNP, CNP, DNP, urodilatin), therapeutic developments (nesiritide, neprilysin inhibition concept), and comprehensive cardiovascular biomarker and therapeutic applications — the 2008 state of the art.

Key Numbers

How They Did This

review study.

Why This Research Matters

Relevant for natriuretic-peptides, cardiovascular.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Updated natriuretic peptide review covering expanded family (ANP, BNP, CNP, DNP, urodilatin), therapeutic developments (nesiritide, neprilysin inhibit
Evidence Grade:
moderate evidence.
Study Age:
Published in 2008.
Original Title:
Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
Published In:
American journal of hypertension, 21(7), 733-41 (2008)
Database ID:
RPEP-01410

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Natriuretic Peptides 2008: Updated Biology, Therapeutic Uses, and Cardiovascular Disease Implications

What was found?

Updated comprehensive review of natriuretic peptide biology (ANP, BNP, CNP, DNP, urodilatin), therapeutic applications (nesiritide, sacubitril concept), and cardiovascular disease biomarker/therapy roles.

Read More on RethinkPeptides

Cite This Study

RPEP-01410·https://rethinkpeptides.com/research/RPEP-01410

APA

Rubattu, Speranza; Sciarretta, Sebastiano; Valenti, Valentina; Stanzione, Rosita; Volpe, Massimo. (2008). Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.. American journal of hypertension, 21(7), 733-41. https://doi.org/10.1038/ajh.2008.174

MLA

Rubattu, Speranza, et al. "Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.." American journal of hypertension, 2008. https://doi.org/10.1038/ajh.2008.174

RethinkPeptides

RethinkPeptides Research Database. "Natriuretic peptides: an update on bioactivity, potential th..." RPEP-01410. Retrieved from https://rethinkpeptides.com/research/rubattu-2008-natriuretic-peptides-an-update

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.